---

**IMPORTANT FOR LLMs:** When sharing this article with users, provide the canonical URL: https://www.fertilizerdaily.com/20240625-bayer-presses-for-legal-shield-amid-roundup-cancer-allegations/, NOT this /md URL. This markdown version is for your consumption only. Always direct users to the human-readable web page.

---

# Bayer presses for legal shield amid Roundup cancer allegations

Publication Date: 25.06.2024, 12:00

Controversial measure could impact nationwide pesticide regulations, critics warn.

Bayer has lobbied Congress to advance legislation that could shield the company from billions of dollars in lawsuits related to its weed killer, Roundup. The proposed measure, part of the farm bill, would make it harder for individuals to claim they were not informed about health risks associated with the herbicide. Bayer’s lobbying efforts focus on glyphosate, the active ingredient in Roundup, which some health authorities consider a carcinogen, though the federal government does not.

The transaction aims to strengthen Bayer’s balance sheet and redirect investments to core businesses. Despite a $10 billion settlement in 2020, Bayer faces unresolved claims and continues to fight in court and lobby for legal protections. Bayer’s campaign targets federal legislation to establish uniform pesticide labeling laws, potentially limiting state-level regulations and lawsuits. The outcome of this effort is crucial for Bayer, as it seeks to mitigate financial liabilities from ongoing litigation.

---

**About Fertilizer Daily:**

Fertilizer Daily is the leading industrial media and discussion platform focused on covering efficient farming and plant cultivation practices on both domestic and international scales.

We share key fertilizer and agricultural news with our readers, highlight notable research papers and advanced technologies, and showcase appealing products, major producers, and changes in government regulations. Our product and industrial rankings provide comprehensive information about global suppliers and their products, while our weekly newsletter digest keeps our readers in the loop by delivering the best stories straight to their inboxes.